| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3947003 | Gynecologic Oncology | 2012 | 4 Pages |
Abstract
⺠Sequential estradiol-progestin therapy associates with risk for primary fallopian tube cancer. ⺠Types of progestins or doses of estradiol were no determinants for the risk rise.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Virpi Koskela-Niska, Annika Riska, Heli Lyytinen, Eero Pukkala, Olavi Ylikorkala,